Functional characterization of the novel DES mutation p.L136P associated with dilated cardiomyopathy reveals a dominant filament assembly defect.

Andreas Brodehl, Mareike Dieding, Niklas Biere, Andreas Unger, Bärbel Klauke, Volker Walhorn, Jan Gummert, Uwe Schulz, Wolfgang A Linke, Brenda Gerull, Matthias Vorgert, Dario Anselmetti, Hendrik Milting

Journal: Journal of molecular and cellular cardiology 2016;91():207-14

PMID: 26724190

Abstract

BACKGROUND

Dilated cardiomyopathy (DCM) could be caused by mutations in more than 40 different genes. However, the pathogenic impact of specific mutations is in most cases unknown complicating the genetic counseling of affected families. Therefore, functional studies could contribute to distinguish pathogenic mutations and benign variants. Here, we present a novel heterozygous DES missense variant (c.407C>T; p.L136P) identified by next generation sequencing in a DCM patient. DES encodes the cardiac intermediate filament protein desmin, which has important functions in mechanical stabilization and linkage of the cell structures in cardiomyocytes.

METHODS AND RESULTS

Cell transfection experiments and assembly assays of recombinant desmin in combination with atomic force microscopy were used to investigate the impact of this novel DES variant on filament formation. Desmin-p.L136P forms cytoplasmic aggregates indicating a severe intrinsic filament assembly defect of this mutant. Co-transfection experiments of wild-type and mutant desmin conjugated to different fluorescence proteins revealed a dominant affect of this mutant on filament assembly. These experiments were complemented by apertureless scanning near-field optical microscopy.

CONCLUSION

In vitro analysis demonstrated that desmin-p.L136P is unable to form regular filaments and accumulate instead within the cytoplasm. Therefore, we classified DES-p.L136P as a likely pathogenic mutation. In conclusion, the functional characterization of DES-p.L136P might have relevance for the genetic counseling of affected families with similar DES mutations and could contribute to distinguish pathogenic mutations from benign rare variants.

Copyright © 2016 Elsevier Ltd. All rights reserved.

Address: Erich and Hanna Klessmann Institute for Cardiovascular Research & Development (EHKI), Heart and Diabetes Center NRW, Ruhr University Bochum, D-32545 Bad Oeynhausen, Germany; Libin Cardiovascular Institute of Alberta, Department of Cardiac Sciences, University of Calgary, 3280 Hospital Drive NW, T2N4Z6 Calgary, AB, Canada. Electronic address: [email protected].; Experimental Biophysics and Applied Nanoscience, Faculty of Physics and Bielefeld Institute for Biophysics and Nanoscience (BINAS), Bielefeld University, D-33615 Bielefeld, Germany.; Department of Cardiovascular Physiology, Ruhr University Bochum, D-44780 Bochum, Germany.; Erich and Hanna Klessmann Institute for Cardiovascular Research & Development (EHKI), Heart and Diabetes Center NRW, Ruhr University Bochum, D-32545 Bad Oeynhausen, Germany.; Libin Cardiovascular Institute of Alberta, Department of Cardiac Sciences, University of Calgary, 3280 Hospital Drive NW, T2N4Z6 Calgary, AB, Canada.; Neurologische Klinik und Poliklinik, Universitätsklinikum Bergmannsheil, Buerkle-de-la-Camp-Platz 1, D-44789 Bochum, Germany.; Erich and Hanna Klessmann Institute for Cardiovascular Research & Development (EHKI), Heart and Diabetes Center NRW, Ruhr University Bochum, D-32545 Bad Oeynhausen, Germany. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.